Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival

Authors:

Abstract
BACKGROUND: Patients who travel a long distance (≥50 miles) for cancer care have improved outcomes. However, to the authors' knowledge, the prevalence of long travel distances for treatment by patients with head and neck squamous cell carcinoma (HNSCC), and the effect of travel distance on overall survival (OS), remains unknown. METHODS: The authors used the National Cancer Data base from 2004 through 2013 to identify patients with HNSCC undergoing definitive treatment. Travel distance for treatment was categorized as short (P <.001). Traveling a long distance for treatment was associated with improved OS on multivariable analysis (adjusted hazard ratio, 0.93; 95% confidence interval, 0.89‐0.96) compared with a short distance. CONCLUSIONS: Traveling a long distance for HNSCC treatment is associated with improved survival, especially for patients receiving nonsurgical management. Racial and ethnic disparities in travel for HNSCC treatment exist. As regionalization of care continues, future work should identify and address reasons for racial and ethnic disparities in travel that may prevent access to care at high‐volume facilities. Cancer 2018;000:000‐000 . © 2018 American Cancer Society .
Funding Information
  • Biostatistics Shared Resource of Hollings Cancer Center at the Medical University of South Carolina (P30 CA138313)
  • Comparative Effectiveness Data Analytics Resources (CEDAR) core
  • Medical University of South Carolina Office of the Provost
  • South Carolina Clinical and Translational Research (SCTR) Institute of the Medical University of South Carolina (NCATS UL1 TR001450)

This publication has 25 references indexed in Scilit: